De subitaneis mortibus. XXIII. Rheumatoid arthritis and ankylosing spondylitis

Circulation
|April 1, 1977
PubMed

Insights

Rheumatoid arthritis and ankylosing spondylitis can cause severe heart conduction problems, including heart block and arrhythmias. Necropsy revealed significant degeneration in the heart

Area of Science:

  • Cardiovascular Pathology
  • Rheumatic Diseases
  • Cardiac Electrophysiology

Background:

  • Investigating the cardiac conduction system in patients with rheumatic diseases is crucial for understanding sudden cardiac death.
  • Rheumatoid arthritis and ankylosing spondylitis are systemic inflammatory conditions that can affect multiple organs, including the heart.

Observation:

  • Necropsy examination of three patients (two with rheumatoid arthritis, one with ankylosing spondylitis) revealed significant cardiac conduction system abnormalities.
  • All patients exhibited cardiac electrical instability, with two experiencing sudden death.
  • Histological findings included sinus node degeneration, and degenerative disease in the atrioventricular (A-V) node and His bundle.

Findings:

  • Electrophysiological abnormalities ranged from atrial fibrillation to complete heart block.
  • Marked narrowing, and in some cases virtual occlusion, of the nutrient arteries supplying the A-V node and His bundle was observed.
  • Sinus node degeneration was present in all cases, though sinus node arteries were not significantly abnormal.

Implications:

  • These findings suggest a strong link between rheumatic disease, cardiac conduction system pathology, and potentially fatal arrhythmias.
  • Understanding these pathological mechanisms may inform strategies for managing cardiac complications in patients with rheumatoid arthritis and ankylosing spondylitis.
  • Comparison with cardiac findings in other connective tissue diseases like lupus, polyarteritis nodosa, and scleroderma highlights shared and distinct pathological pathways.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...